Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab + MTX vs MTX in Psoriatic Arthritis (GO-DACT)
NCT02065713Phase 3Completed
- Sponsor
- Instituto de Medicina Molecular João Lobo Antunes
- Start
- Aug 2014
- Primary completion
- Jun 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in psoriatic arthritis (PsA), sponsored by Instituto de Medicina Molecular João Lobo Antunes. Started Aug 2014; status: completed.
02
Drugs
golimumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT02065713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065713.